Duane Johnson

Title: Duane Johnson: Innovator in Cancer Treatment

Introduction

Duane Johnson is a notable inventor based in Encinitas, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the therapeutic use of the retinoblastoma susceptibility gene product, which has implications for preventing and treating certain types of cancer.

Latest Patents

Duane Johnson holds 1 patent for his invention titled "Therapeutic use of the retinoblastoma susceptibility gene product." This invention provides a method for preventing or inhibiting the proliferation of pathologically proliferating cells. The method addresses the absence of a functional retinoblastoma protein or polypeptide in the cell. By contacting the cell with an effective amount of retinoblastoma protein or polypeptide, this method can help prevent or treat retinoblastoma or secondary cancers associated with it.

Career Highlights

Throughout his career, Duane Johnson has worked with prestigious institutions, including the University of California and Canji Inc. His research has been instrumental in advancing the understanding of cancer biology and developing potential therapeutic strategies.

Collaborations

Duane has collaborated with esteemed colleagues such as Wen-Hwa Lee and Eva Y-hp Lee. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Duane Johnson's innovative work in cancer treatment exemplifies the impact of scientific research on healthcare. His contributions continue to pave the way for advancements in the prevention and treatment of cancer.